Li Cai-Xia, Li Li, Zhang Jin-Feng, Zhang Qi-Hong, Jin Xiao-Hong, Cai Guo-Juan
Department of Critical Care, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang Province, China.
Department of Emergency, Zhuji People's Hospital of Zhejiang Province, Zhuji 311800, Zhejiang Province, China.
World J Clin Cases. 2021 Nov 26;9(33):10106-10115. doi: 10.12998/wjcc.v9.i33.10106.
Hypertensive cerebral hemorrhage (HICH) is the rupture and bleeding of vessels of the cerebral parenchyma caused by continuously elevated or violently fluctuating blood pressure. The condition is characterized by high disability and high mortality. Hematoma formation and resulting space-occupying effects following intracerebral hemorrhage are among the key causes of impaired neurological function and disability. Consequently, minimally invasive clearance of the hematoma is undertaken for the treatment of HICH because it can effectively relieve intracranial hypertension. Therefore, special attention should be given to the quality of medical and nursing interventions in the convalescent period after minimally invasive hematoma clearance.
The study aim was to determine the value of intensive intervention, including doctors, nurses, and patient families, for the prevention of rebleeding in elderly patients with HICH during the first hospitalization for rehabilitation after the ictal event.
A total of 150 elderly HICH patients with minimally invasive hematoma evacuation in our hospital between May 2018 and May 2020 were selected and equally divided into two groups of 75 each by their planned intervention. The control group was given conventional nursing intervention and the observation group was given tripartite intensive intervention. The length of hospital stay, cost, complication rate, satisfaction rate, and rebleeding rate during hospitalization were recorded. Changes in cerebral blood flow indicators were recorded in both groups. Changes in the National Institutes of Health Stroke Scale (NIHSS) score, quality of life index (QLI) score, and health behavior score were evaluated at the National Institutes of Health.
Duration of hospitalization was shorter in the in the observation group than in the control group, the hospitalization cost was less than in the control group, and the rate of rebleeding during hospitalization was lower than in the control group (all < 0.05). There were no significant differences between the two groups before treatment (all > 0.05). The mean flow rate (Q) and mean velocity (V) of the two groups increased ( < 0.05), and the dynamic resistance and peripheral resistance decreased ( < 0.05). The Q and V in the intervention group were higher than those in the control group ( < 0.05). Moreover, the dynamic resistance and peripheral resistance of the blood vessels were also lower in the intervention group than in the control group ( < 0.05). The difference in health behavior scores between the two groups before treatment was not significant ( > 0.05). In both groups, the scores for healthy behaviors such as emotion control, medication adherence, dietary management, exercise management, and self-monitoring were higher after than before treatment ( < 0.05), and the scores of healthy behaviors in the intervention group were higher than those in the control group ( < 0.05). There was no significant difference in the NIHSS and QLI scores between the two groups before treatment ( > 0.05). The QLI scores of the two groups increased ( < 0.05), and the NIHSS scores decreased ( < 0.05). The QLI scores of the intervention group were higher than those of the control group ( < 0.05), and the NIHSS score was correspondingly lower than that of the control group ( < 0.05). The incidence of respiratory infections, pressure sores, central hyperpyrexia, and deep venous thrombosis was lower in the intervention group than in the control group. Accordingly, the satisfaction rate was higher in the treatment group than that in the control group ( < 0.05).
Intensive intervention by doctors, nurses, and families of elderly patients with HICH reduced the rate of rebleeding during hospitalization. It also reduced the incidence of complications, promoted rehabilitation, improved the quality of life, and enhanced nerve function. Additionally, it improved satisfaction and promoted healthy behaviors.
高血压性脑出血(HICH)是由血压持续升高或剧烈波动导致脑实质血管破裂出血。该病具有高致残率和高死亡率的特点。脑出血后血肿形成及其占位效应是神经功能受损和致残的关键原因之一。因此,微创清除血肿被用于治疗HICH,因为它能有效缓解颅内高压。所以,在微创血肿清除术后的康复期,应特别关注医疗和护理干预的质量。
本研究旨在确定包括医生、护士和患者家属在内的强化干预措施对预防老年HICH患者首次住院康复期间再出血的价值。
选取2018年5月至2020年5月在我院接受微创血肿清除术的150例老年HICH患者,根据计划干预措施将其平均分为两组,每组75例。对照组给予常规护理干预,观察组给予三方强化干预。记录住院时间、费用、并发症发生率、满意度及住院期间再出血率。记录两组脑血流指标的变化。在美国国立卫生研究院评估美国国立卫生研究院卒中量表(NIHSS)评分、生活质量指数(QLI)评分和健康行为评分的变化。
观察组住院时间短于对照组,住院费用低于对照组,住院期间再出血率低于对照组(均P<0.05)。两组治疗前差异无统计学意义(均P>0.05)。两组的平均血流量(Q)和平均流速(V)均升高(P<0.05),动态阻力和外周阻力降低(P<0.05)。干预组的Q和V高于对照组(P<0.05)。此外,干预组血管的动态阻力和外周阻力也低于对照组(P<0.05)。两组治疗前健康行为评分差异无统计学意义(P>0.05)。两组治疗后情绪控制、服药依从性、饮食管理、运动管理和自我监测等健康行为评分均高于治疗前(P<0.05),且干预组健康行为评分高于对照组(P<0.05)。两组治疗前NIHSS和QLI评分差异无统计学意义(P>0.05)。两组的QLI评分升高(P<0.05),NIHSS评分降低(P<0.05)。干预组的QLI评分高于对照组(P<0.05),NIHSS评分相应低于对照组(P<0.05)。干预组呼吸道感染、压疮、中枢性高热和深静脉血栓形成的发生率低于对照组。因此,治疗组的满意度高于对照组(P<0.05)。
医生、护士和老年HICH患者家属的强化干预降低了住院期间的再出血率。还降低了并发症的发生率,促进了康复,提高了生活质量,增强了神经功能。此外,提高了满意度,促进了健康行为。